Clinical Trial Update: Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin [NA]

View source ↗

Summary

A completed trial evaluated the efficacy and safety of the oral Eligen B12 formulation in individuals with low serum cobalamin. The sponsor was Emisphere Techno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitamin B12 Deficiency

Drugs mentioned

• Eligen B12

Snippet

Sponsor: Emisphere Technologies, Inc. | Conditions: Vitamin B 12 Deficiency | NA | Status: COMPLETED